Sanna Salanterä

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Elin Carlsson

> Home > Persons > Sanna Salanterä

Publications

2011
[j4]
- view
  - electronic edition @ jbiomedsem.com
  - details & citations
- export record
  dblp key:
  - journals/biomedsem/AllvinCDDDHKLNNSSSV11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/biomedsem/AllvinCDDDHKLNNSSSV11
Helen Allvin, Elin Carlsson, Hercules Dalianis, Riitta Danielsson-Ojala, Vidas Daudaravicius, Martin Hassel, Dimitrios Kokkinakis, Heljä Lundgrén-Laine, Gunnar H. Nilsson, Øystein Nytrø, Sanna Salanterä, Maria Skeppstedt, Hanna Suominen, Sumithra Velupillai:
Characteristics of Finnish and Swedish intensive care nursing narratives: a comparative analysis to support the development of clinical language technologies. J. Biomed. Semant. 2(S-3): S1 (2011)
2010
[c8]
- view
  - electronic edition @ aclanthology.org (open access)
  - details & citations
- export record
  dblp key:
  - conf/acl-louhi/AllvinCDDDHKLNN10
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/acl-louhi/AllvinCDDDHKLNN10
Helen Allvin, Elin Carlsson, Hercules Dalianis, Riitta Danielsson-Ojala, Vidas Daudaravicius, Martin Hassel, Dimitrios Kokkinakis, Heljä Lundgrén-Laine, Gunnar H. Nilsson, Øystein Nytrø, Sanna Salanterä, Maria Skeppstedt, Hanna Suominen, Sumithra Velupillai:
Characteristics and Analysis of Finnish and Swedish Clinical Intensive Care Nursing Narratives. Louhi@NAACL-HLT 2010: 53-60

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.